Aquatic Capital Management LLC

Position in GSK — GSK plc

CIK 1803916 CHICAGO, IL

Position in GSK

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,257,205

+$1,922,644 QoQ

Shares Held

43,060

+610.3% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

#235

of 1,033 holders

Holding Since

Mar 2022

16 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Aquatic Capital Management LLC holds $26,569,563 across 5 Drug Manufacturers - General names. GSK ranks #4 (8.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AZN	Astrazeneca PLC	68,181	$12,928,481
2	AMGN	Amgen Inc	18,128	$6,564,511
3	GILD	Gilead Sciences, Inc.	29,446	$3,720,207
4	GSK	GSK plc This page	43,060	$2,257,205
5	BMY	Bristol Myers Squibb Co	19,076	$1,099,159

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,257,205	43,060	+610.3%	Shares	Sole	2026-08-14
2026-03-31	$334,561	6,062	-98.3%	Shares	Sole	2026-05-15
2025-12-31	$17,547,345	357,817	+112.4%	Shares	Sole	2026-02-17
2025-09-30	$7,271,381	168,475	-60.9%	Shares	Sole	2025-11-14
2025-06-30	$16,529,856	430,465	+29.4%	Shares	Sole	2025-08-14
2025-03-31	$12,888,836	332,701	-21.5%	Shares	Sole	2025-05-15
2024-12-31	$14,332,780	423,796	+155.8%	Shares	Sole	2025-02-14
2024-09-30	$6,773,816	165,700	+53.6%	Shares	Sole	2024-11-14
2024-06-30	$4,154,150	107,900	+83.2%	Shares	Sole	2024-08-14
2024-03-31	$2,525,043	58,900	-23.5%	Shares	Sole	2024-05-15
2023-12-31	$2,853,620	77,000	-3.4%	Shares	Sole	2024-02-14
2023-09-30	$2,889,125	79,700	+9.5%	Shares	Sole	2023-11-14
2023-06-30	$2,594,592	72,800	+141.1%	Shares	Sole	2023-08-14
2022-09-30	$888,786	30,200	+187.6%	Shares	Sole	2022-11-14
2022-06-30	$448,289	10,500	+1400.0%	Shares	Sole	2022-08-15
2022-03-31	$29,906	700	—	Shares	Sole	2022-05-16
No filing history on record for this holder in this stock.